Impact of medical therapy on transurethral resection of the prostate: A decade of change

被引:60
作者
Borth, CS [1 ]
Beiko, DT [1 ]
Nickel, JC [1 ]
机构
[1] Queens Univ, Dept Urol, Kingston, ON, Canada
关键词
D O I
10.1016/S0090-4295(01)01018-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To assess whether medical therapy has delayed the need for eventual transurethral prostatectomy (TURP), causing a shift in the population characteristics of men undergoing TURF tie, older, more comorbidities, more advanced disease), resulting in more complications and poorer outcomes. The introduction of medical therapy for symptomatic benign prostatic hyperplasia (BPH) during the past decade may have changed the indications for TURF. Methods. Ail patients who underwent TURF for symptomatic BPH at our institution in 1988 (before general introduction of medical therapy for BPH) and 1998 (medical therapy the primary initial therapy for BPH) were reviewed. We compared the two groups with respect to the total number of TURPs, indications for surgery, patient age, health status, weight of resected tissue, and preoperative and postoperative complications. Results. Despite a 16% increase in men at risk of BPH-related events, a 60% decrease in the total number of TURPs performed for symptomatic BPH occurred in 1998 (n = 64) compared with 10 years earlier (n = 157). No significant difference was found in age between the two groups, and no increase in comorbid status was observed. Previous medical management had failed in 36% of men who required TURF in 1998. A significantly higher percentage of patients presented in acute urinary retention [55%) and upper tract obstructive uropathy (12.5%) in 1998 compared with 1988 (23% acute urinary retention and 1.3% obstructive uropathy). Patients in 1998 were healthier, underwent smaller resections, had their catheters removed earlier, and were discharged home earlier. Although they were more likely to be discharged home with a catheter in situ, no significant difference was observed in the incidence of postoperative complications. Conclusions. There has been a dramatic decrease in the number of TURPs performed for symptomatic BPH at our institution since the advent of medical therapy. The proportion of TURF patients presenting with urinary retention and hydronephrosis increased, but the average age, medical comorbidities, operative parameters, and postoperative complications have not significantly changed. UROLOGY 57: 1082-1086, 2001. (C) 2001, Elsevier Science Inc.
引用
收藏
页码:1082 / 1085
页数:4
相关论文
共 12 条
[1]   Immediate and postoperative complications of transurethral prostatectomy in the 1990s [J].
Borboroglu, PG ;
Kane, CJ ;
Ward, JF ;
Roberts, JL ;
Sands, JP .
JOURNAL OF UROLOGY, 1999, 162 (04) :1307-1310
[2]   THE PREVALENCE OF PROSTATISM - A POPULATION-BASED SURVEY OF URINARY SYMPTOMS [J].
CHUTE, CG ;
PANSER, LA ;
GIRMAN, CJ ;
OESTERLING, JE ;
GUESS, HA ;
JACOBSEN, SJ ;
LIEBER, MM .
JOURNAL OF UROLOGY, 1993, 150 (01) :85-89
[3]   HIGH PREVALENCE OF BENIGN PROSTATIC HYPERTROPHY IN THE COMMUNITY [J].
GARRAWAY, WM ;
COLLINS, GN ;
LEE, RJ .
LANCET, 1991, 338 (8765) :469-471
[4]   Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia [J].
Holtgrewe, HL .
UROLOGY, 1998, 51 (4A) :1-7
[5]  
Horninger W, 1996, PROSTATE, V28, P195
[6]   Recent developments in the surgical management of benign prostatic hyperplasia [J].
Jepsen, JV ;
Bruskewitz, RC .
UROLOGY, 1998, 51 (4A) :23-31
[7]   Pharmacologic therapy for prostatism [J].
Lieber, MM .
MAYO CLINIC PROCEEDINGS, 1998, 73 (06) :590-596
[8]   The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia [J].
McConnell, JD ;
Bruskewitz, R ;
Walsh, P ;
Andriole, G ;
Lieber, M ;
Holtgrewe, HL ;
Albertsen, P ;
Roehrborn, CG ;
Nickel, JC ;
Wang, DZ ;
Taylor, AM ;
Waldstreicher, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (09) :557-563
[9]  
MEBUST WK, 1994, PROG CLIN BIOL RES, V386, P369
[10]   Overview of α-blocker therapy for benign prostatic hyperplasia [J].
Narayan, P ;
Tewari, A .
UROLOGY, 1998, 51 (4A) :38-45